These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22819579)

  • 21. An analysis of whole body tracer kinetics in dynamic PET studies with application to image-based blood input function extraction.
    Huang J; O'Sullivan F
    IEEE Trans Med Imaging; 2014 May; 33(5):1093-108. PubMed ID: 24770914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methodology for quantitative rapid multi-tracer PET tumor characterizations.
    Kadrmas DJ; Hoffman JM
    Theranostics; 2013 Oct; 3(10):757-73. PubMed ID: 24312149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron Emission Tomography Computed Tomography: A Guide for the General Radiologist.
    Beadsmoore C; Newman D; MacIver D; Pawaroo D
    Can Assoc Radiol J; 2015 Nov; 66(4):332-47. PubMed ID: 26277234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative techniques in 18FDG PET scanning in oncology.
    Castell F; Cook GJ
    Br J Cancer; 2008 May; 98(10):1597-601. PubMed ID: 18475291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative, simultaneous PET/MRI for intratumoral imaging with an MRI-compatible PET scanner.
    Ng TS; Bading JR; Park R; Sohi H; Procissi D; Colcher D; Conti PS; Cherry SR; Raubitschek AA; Jacobs RE
    J Nucl Med; 2012 Jul; 53(7):1102-9. PubMed ID: 22661534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging Cancer Metabolism with Positron Emission Tomography (PET).
    Witney TH; Lewis DY
    Methods Mol Biol; 2019; 1928():29-44. PubMed ID: 30725448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transconvolution and the virtual positron emission tomograph--a new method for cross calibration in quantitative PET∕CT imaging.
    Prenosil GA; Weitzel T; Hentschel M; Klaeser B; Krause T
    Med Phys; 2013 Jun; 40(6):062503. PubMed ID: 23718608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative radiomics: Validating image textural features for oncological PET in lung cancer.
    Yang F; Young LA; Johnson PB
    Radiother Oncol; 2018 Nov; 129(2):209-217. PubMed ID: 30279049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative PET in the 2020s: a roadmap.
    Meikle SR; Sossi V; Roncali E; Cherry SR; Banati R; Mankoff D; Jones T; James M; Sutcliffe J; Ouyang J; Petibon Y; Ma C; El Fakhri G; Surti S; Karp JS; Badawi RD; Yamaya T; Akamatsu G; Schramm G; Rezaei A; Nuyts J; Fulton R; Kyme A; Lois C; Sari H; Price J; Boellaard R; Jeraj R; Bailey DL; Eslick E; Willowson KP; Dutta J
    Phys Med Biol; 2021 Mar; 66(6):06RM01. PubMed ID: 33339012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy.
    Kinahan PE; Fletcher JW
    Semin Ultrasound CT MR; 2010 Dec; 31(6):496-505. PubMed ID: 21147377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on novel quantitative techniques in the context of evolving whole-body PET imaging.
    Houshmand S; Salavati A; Hess S; Werner TJ; Alavi A; Zaidi H
    PET Clin; 2015 Jan; 10(1):45-58. PubMed ID: 25455879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-fluorodeoxyglucose PET/CT in cancer imaging.
    Kayani I; Groves AM
    Clin Med (Lond); 2006; 6(3):240-4. PubMed ID: 16826854
    [No Abstract]   [Full Text] [Related]  

  • 33. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
    Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
    J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients.
    Dimitrakopoulou-Strauss A; Pan L; Strauss LG
    Cancer Imaging; 2012 Sep; 12(1):283-9. PubMed ID: 23033440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
    Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice.
    Al-Nabhani KZ; Syed R; Michopoulou S; Alkalbani J; Afaq A; Panagiotidis E; O'Meara C; Groves A; Ell P; Bomanji J
    J Nucl Med; 2014 Jan; 55(1):88-94. PubMed ID: 24337608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study.
    Satoh Y; Motosugi U; Imai M; Onishi H
    Ann Nucl Med; 2020 Feb; 34(2):119-127. PubMed ID: 31768819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Added value of PET and PET-computed tomography in oesophageal cancer: a review of current practice.
    Douis H; Jafri M
    Nucl Med Commun; 2008 Sep; 29(9):840. PubMed ID: 18677217
    [No Abstract]   [Full Text] [Related]  

  • 39. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
    Hallett WA; Maguire RP; McCarthy TJ; Schmidt ME; Young H
    IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined imaging modalities: PET/CT and SPECT/CT.
    Maurer AH
    Health Phys; 2008 Nov; 95(5):571-6. PubMed ID: 18849691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.